Bio-Techne CorporationTECH
NasdaqGS•Healthcare•Biotechnology
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $1.21B, growing 0.2% year-over-year. TTM net income stood at $109.56M (16.8% contraction). Quarterly EBITDA was $99.66M and operating income was $75.50M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze TECH growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters